Press Release

Metagenomics Sequencing Market to be dominated by Whole genome sequencing & de novo assembly through 2028.

The rise in research and development activities for development of new drugs is expected to drive the growth of Global Metagenomics Sequencing Market during the forecast period, 2024-2028.

According to TechSci Research report, “Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global Metagenomics Sequencing Market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the research and development activities for development of novel drugs and growing demand for advanced sequencing technology across the region. Additionally, growing applications of metagenomics in different fields such as bioremediation, ecological and environmental metagenomics, clinical diagnostics, drug development, and industrial use are the major factors driving the growth of the market during the forecast period. Also, growing adoption of bioinformatics technology in the diagnostic procedures and growing demand for discovery of new proteins such as antibiotics by purifying, cloning, and expressing DNA taken from the organisms will further boost the growth of the Global Metagenomics Sequencing Market in the forecast period. Besides, Governments around the world are providing support for development of healthcare industry, including funding for research and development, which is driving the demand for Metagenomics Sequencing Market during the forecast period.

However, the cost of metagenomics sequencing can be high, particularly for high-throughput sequencing technologies. This can slow down the growth of the Global Metagenomics Sequencing Market in the forecast period. Also, Metagenomics sequencing generates vast amounts of data that can be difficult to analyze and interpret. Advanced bioinformatics tools and expertise are often required to extract meaningful insights from the data, creating a challenge,  further restricting the growth of the Global Metagenomics Sequencing Market. Similarly, lack of standardization about metagenomics sequencing machine along with Environmental samples can contain diverse microbial communities with varying abundance levels, making it challenging to capture and sequence the entire microbial diversity accurately that may hamper the growth of the market during the forecast period.


Browse over XX market data Figures spread through xx Pages and an in-depth TOC on "Global Metagenomics Sequencing Market.


Metagenomics Sequencing market can be segmented by product and service, technology, application, and region.

Based on the Technology, the Global Metagenomics Sequencing Market can be segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and meta transcriptomics. The whole genome sequencing & de novo assembly segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to increasing Technological breakthroughs about genomic sequencing such as meta proteomics, meta transcriptomics along with rising research and development spending on the genome research for the development of novel drugs, techniques for the treatment of chronic diseases  and increased knowledge of metagenomics among healthcare providers. Also, growing investments are being made by firms that are developing the next generation of genomics and bioinformatics, i.e., expected to create lucrative growth during the forecast period.

Based on Application, the market can be segmented into drug discovery, ecological & environmental metagenomics, clinical diagnostics, biofuel, and industrial applications. The drug discovery segment is expected to dominate during the forecast period on account of the increasing research and development activities on the genomic sequencing in the pharmaceutical and biotechnology industries for novel drug discovery for exploring the antimicrobial activity along with collaboration between market players and academic institutes.

Major companies operating in the Global Metagenomics Sequencing Market are:

·         BGI Genomics Co Ltd.

·         Eurofins Scientific Se.

·         Illumina Inc.

·         Macrogen Inc.

·         Oxford Nanopore Technologies Ltd.

·         Pacific Biosciences of California Inc.

·         Perkinelmer Inc.

·         Qiagen N.V.

·         Swift Biosciences Inc.

·         Thermo Fisher Scientific Inc.

In December 2021, Oriel Research announced the launched of metagenomics pipeline. It is being used for supporting metagenomics analysis to allow the full synergism between big data used for bioinformatics analytical tools and novel biological platforms, for delivering metagenomics discoveries to patients.

In June 2021, Illumina announced an agreement with the Belgian Genetic Centers to evaluate whole genome sequencing for the diagnosis of patients with intellectual disabilities and developmental disorders.

Pacific Biosciences (PacBio) launched the Sequel II System in 2019. This long-read sequencing platform offers high-accuracy sequencing and longer read lengths, making it valuable for metagenomics studies. The system allows for better assembly of complex microbial genomes and improved characterization of microbial community structures.

In February 2021, PacBio announced that Childrens Mercy Kansas City increased its investment in highly accurate HiFi sequencing with four new Sequel Ile Systems to add to its two existing Sequel Ile Systems.

Download Sample Report

Customers can also request for 10% free customization on this report.

“North America is expected to dominate in the Global Metagenomics Sequencing Market \due to the growing well established healthcare infrastructure along with growing demand for advance sequencing technique for easy detection of diseases across the region. Similarly, growing interest of researchers in the field of meta transcriptomics, metabolomics, and metaproteomic and investments in bioinformatics to promote metagenomics and microbiome is expected to create lucrative growth in the market during the forecast period. Also, growing concern about viral diseases such as hepatitis-B, HIV/AIDS, influenza, diarrhea along with growing research and development for identifying the genes of the viral diseases are expected to drive the growth of the market during the forecast period. Furthermore, growing availability of technologically advanced product and robust sample processing and library preparation assay kits for exploring the genome activity , and the demand for efficient library preparation products will further be expected to create lucrative opportunities for market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”

Segmented By Product and Service (Reagents & consumables, Instruments, Services), By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics), By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications), By Region and By Competition”, has evaluated the future growth potential of global Metagenomics Sequencing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Metagenomics Sequencing market.


Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web: https://www.techsciresearch.com

Relevant News